Serum vitamin D levels and vitamin D receptor gene ApaI and TaqI polymorphisms in patients with morphea: a case–control study

[1]  D. Ye,et al.  Associations of Vitamin D Receptor Single Nucleotide Polymorphisms with Susceptibility to Systemic Sclerosis. , 2019, Archives of medical research.

[2]  Da-guan Zhang,et al.  The association between vitamin D receptor polymorphisms and serum 25-hydroxyvitamin D levels with ulcerative colitis in Chinese Han population. , 2017, Clinics and research in hepatology and gastroenterology.

[3]  A. Antonelli,et al.  Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature , 2017, Clinical Rheumatology.

[4]  T. Ibrahim,et al.  The vitamin D receptor agonist, calcipotriol, modulates fibrogenic pathways mitigating liver fibrosis in-vivo: An experimental study. , 2016, European journal of pharmacology.

[5]  K. Amr,et al.  Evaluation of the correlation between serum levels of vitamin D and vitamin D receptor gene polymorphisms in an Egyptian population , 2016, International journal of dermatology.

[6]  I. Siam,et al.  Association of VDR ApaI and TaqI Gene Polymorphisms with the Risk of Scleroderma and Behçet’s Disease , 2016, Immunological investigations.

[7]  D. Bikle.  Extraskeletal actions of vitamin D , 2016, Annals of the New York Academy of Sciences.

[8]  G. Çan,et al.  The Prevalence of Vitamin D Deficiency in Children, Adolescents and Adults in a Sample of Turkish Population , 2016 .

[9]  F. Sılan,et al.  Vitamin D Receptor Gene BSMI, FOKI, APAI, and TAQI Polymorphisms and the Risk of Atopic Dermatitis. , 2016, Journal of investigational allergology & clinical immunology.

[10]  P. Lips,et al.  Diet, sun, and lifestyle as determinants of vitamin D status , 2014, Annals of the New York Academy of Sciences.

[11]  S. Doǧru-Abbasoǧlu,et al.  Analysis of Vitamin D Receptor Gene Polymorphisms in Vitiligo , 2012, Dermatology.

[12]  Henry W. Lim,et al.  A dermatologist's perspective on vitamin D. , 2012, Mayo Clinic proceedings.

[13]  Y. Shoenfeld,et al.  Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. , 2011, Autoimmunity reviews.

[14]  V. Werth,et al.  Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. , 2011, Journal of the American Academy of Dermatology.

[15]  Alessandra Dalla Gassa,et al.  Very low levels of vitamin D in systemic sclerosis patients , 2010, Clinical Rheumatology.

[16]  G. Dinç,et al.  Vitamin D status among adults in the Aegean region of Turkey , 2010, BMC public health.

[17]  H. Wulf,et al.  Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation. , 2010, The Journal of investigative dermatology.

[18]  H. Wulf,et al.  Does chronic sunscreen use reduce vitamin D production to insufficient levels? , 2009, The British journal of dermatology.

[19]  Y. Allanore,et al.  Vitamin D Deficiency and Insufficiency in 2 Independent Cohorts of Patients with Systemic Sclerosis , 2009, The Journal of Rheumatology.

[20]  A. Karaduman,et al.  Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients , 2007, Archives of Dermatological Research.

[21]  A. Uitterlinden,et al.  Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.

[22]  C. Black,et al.  Immunocytochemical Localization and Serologic Detection of Transforming Growth Factor β1 , 1994 .

[23]  B. Hollis,et al.  Racial pigmentation and the cutaneous synthesis of vitamin D. , 1991, Archives of dermatology.